בליאומיצין PFI

Riik: Iisrael

keel: heebrea

Allikas: Ministry of Health

Toimeaine:

BLEOMYCIN SULFATE

Saadav alates:

MEGAPHARM LTD

ATC kood:

L01DC01

Ravimvorm:

אבקה להכנת תמיסה לזריקה

Koostis:

BLEOMYCIN SULFATE 15000 IU/VIAL

Manustamisviis:

לתוך קרום הריאה, תוך-עורקי, תוך-ורידי, תת-עורי, תוך-שרירי, לתוך בקע

Retsepti tüüp:

מרשם נדרש

Valmistatud:

BAXTER ONCOLOGY GmbH, GERMANY

Terapeutiline rühm:

BLEOMYCIN

Terapeutiline ala:

BLEOMYCIN

Näidustused:

Bleomycin is useful in the management of the following neoplasms: Squamous cell carcinoma affecting the mouth, nasopharynx and paranasal sinuses, larynx, oesaphagus, cervix, vagina, penis and skin. Well differentiated tumors usually respond better than anaplastic ones.Hodgkin's disease and other malignant lymphomas, including mycosis fungoides. Testicular carcinoma (seminoma and no seminoma) .Malignant effusions of serous cavities (intrapleural and intraperitoneal).Secondary indications in which bleomycin has been shown to be of some value include metastatic malignant melanoma, carcinoma of the thyroid lung and bladder. Local treatment of refractory warts. Bleomycin can be used as a single agent, but is generally used in combination with other cytotoxics and/or with radiation therapy.

Loa andmise kuupäev:

2020-09-30